High-sensitivity Cardiac Troponin Is Not Associated With Acute Cellular Rejection After Heart Transplantation
- 29 June 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 106 (5) , 1024-1030
Abstract
Background.: Acute cellular rejection (ACR) is common in the first year after cardiac transplantation, and regular surveillance endomyocardial biopsy (EMB) is required. An inexpensive, simple noninvasive diagnostic test would be useful. Prior studies suggest cardiac troponin (cTn) has potential as a “rule-out” test to minimize the use of EMB. Our aim was to determine whether a new high-sensitivity cardiac troponin I (hs-cTnI) assay would have utility as a “rule-out” test for ACR after heart transplantation. Methods.: Blood samples at patient follow-up visits were collected and stored over a period of 5 y. Serum cTnI concentrations were measured using the ARCHITECT STAT hs-cTnI assay and compared with an EMB performed on the same day. Receiver-operator curve analysis based on mixed-effects logistic regression models that account for repeated measurements in individuals was performed to determine a serum troponin level below which ACR could be reliably excluded. Results.: One hundred seventy patients had 883 serum hs-cTnI results paired to a routine surveillance EMB. Fifty-one (6%) EMB showed significant ACR (grade ≥2R). Receiver-operator curve analysis approximated the null hypothesis area under the curve 0.509 (95% CI, 0.428-0.591). Sub-analysis including repeated hs-cTnI levels in a single individual, and early (<3 mo) EMB also showed no diagnostic utility of hs-cTnI measurement (area under the curve 0.512). Conclusions.: In the largest published study to date, we found no association between hs-cTnI concentration and the presence of significant ACR on surveillance EMB. Measurement of hs-cTnI may not be a useful technique for diagnosis or exclusion of ACR after heart transplantation.Keywords
This publication has 18 references indexed in Scilit:
- Valor predictivo de la troponina T de alta sensibilidad para descartar el rechazo agudo tras un trasplante cardiacoRevista Espanola de Cardiologia, 2014
- Universal MI Definition Update for Cardiovascular DiseaseCurrent Cardiology Reports, 2014
- High-Sensitivity Cardiac Troponin I Assay to Screen for Acute Rejection in Patients With Heart TransplantCirculation: Heart Failure, 2014
- Do established biomarkers such as B-type natriuretic peptide and troponin predict rejection?Current Opinion in Organ Transplantation, 2013
- High-sensitive Troponin T measurements early after heart transplantation predict short- and long-term survivalTransplant International, 2012
- Concordance Among Pathologists in the Second Cardiac Allograft Rejection Gene Expression Observational Study (CARGO II)Transplantation, 2012
- Utilidad de la prueba de troponina T de alta sensibilidad en la detección de rechazo agudo en trasplante cardiacoRevista Espanola de Cardiologia, 2011
- Short- and Long-Term Cardiac Troponin I Analyte Stability in Plasma and Serum from Healthy Volunteers by Use of an Ultrasensitive, Single-Molecule Counting AssayClinical Chemistry, 2009
- Analytic and Clinical Utility of a Next-Generation, Highly Sensitive Cardiac Troponin I Assay for Early Detection of Myocardial InjuryClinical Chemistry, 2009
- Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart RejectionThe Journal of Heart and Lung Transplantation, 2005